查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1968734

被忽視的熱帶疾病診斷市場分析及預測（至2035年）：按類型、產品類型、服務、技術、應用、最終用戶、設備、流程、組件分類

Neglected Tropical Diseases Diagnosis Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, End User, Device, Process, Component
出版日期: | 出版商: Global Insight Services | 英文 361 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

被忽視的熱帶疾病診斷市場預計將從2024年的67億美元成長到2034年的120億美元，複合年成長率約為6.6%。該市場涵蓋用於識別低收入地區常被忽視的疾病（例如南美錐蟲病、利什曼原蟲症和血吸蟲病）的診斷工具和技術。該市場專注於提供經濟、快速且準確的診斷解決方案，以促進疾病的早期發現和治療。全球衛生舉措的擴展以及研發投入的增加正在推動就地檢驗（POC​​T）和分子診斷技術的進步，從而滿足服務不足地區對便利醫療保健解決方案的迫切需求。

被忽視的熱帶疾病診斷市場預計將迎來顯著成長，這主要得益於診斷技術的進步和公眾意識的提高。血清學檢測領域預計將呈現最高的成長率，因為其準確性和快速出結果對於疾病的早期發現至關重要。分子診斷緊隨其後，受益於PCR和次世代定序技術的廣泛應用，這些技術能夠準確識別病原體。即時診斷因其便攜性和易操作性而日益普及，尤其是在偏遠和資源匱乏的地區。公共和私營部門為消除被忽視的熱帶疾病而進行的投資進一步推動了對創新診斷解決方案的需求。免疫檢測，特別是酵素連結免疫吸附試驗（ELISA），仍然是診斷工具包的基礎，而新生物標記的發現不斷提高檢測的特異性和靈敏度。研究機構、政府和醫療服務提供者之間的合作對於推動市場擴張以及確保流行地區診斷工具的可近性和可負擔性至關重要。

市場區隔
類型 寄生蟲病、病毒病、細菌病、真菌病、原蟲病、蠕蟲病、媒介傳播疾病、通用感染疾病
產品 診斷試劑盒、試劑、儀器、耗材、軟體、配件、檢測方法、試劑盒
服務 檢查服務、諮詢服務、維護服務、訓練服務、資料管理服務
科技 分子診斷、免疫檢測診斷、層析法、質譜法、微陣列、就地檢驗、生物感測器
應用領域 臨床診斷、研究與發展、流行病學調查、公共衛生計畫、獸醫診斷
最終用戶 醫院、診斷檢查室、研究機構、學術機構、公共衛生機構、獸醫診所
裝置 攜帶式、桌上型、穿戴式和手持式設備
過程 檢體採集、檢體製備、分析、數據解釋和報告
成分 硬體、軟體和服務

市場概況：

被忽視的熱帶疾病（NTD）診斷市場正經歷動態變化，創新的定價策略和新產品推出推動了市場佔有率的成長。各公司正著力提升產品的可負擔性和可近性，這對發展中地區的市場至關重要。近期產品創新提高了診斷的準確性和速度，滿足了對有效解決方案的迫切需求。這些發展加劇了市場競爭，並促進了持續的進步和策略聯盟。 NTD診斷市場的競爭日益激烈，主要參與者相互參照以保持市場主導地位。監管的影響至關重要，嚴格的指導方針確保了診斷工具的安全性和有效性。國際衛生組織的政策影響該市場，進而影響產品的開發和核准流程。新興經濟體在資金籌措和公眾意識提升的支持下，正在推動市場成長。技術整合進一步最佳化了市場環境，有望推動診斷能力的提升和市場的擴張。

主要趨勢和促進因素：

由於公眾意識的提高和全球衛生舉措的推動，被忽視的熱帶疾病診斷市場正在成長。各國政府和組織正在加大研發投入，以改善診斷工具。這一趨勢的驅動力在於，需要對威脅弱勢族群的疾病做出緊急應變。技術進步至關重要，推動了快速診斷和就地檢驗的創新。這些技術能夠提供更快、更準確的結果，從而加強疾病管理和控制。因此，對攜帶式和易用型診斷設備的需求日益成長。公私合營正成為關鍵促進因素，促進相關人員之間的協作。這些合作對於資金籌措和資源分配至關重要，確保診斷服務的廣泛普及。此外，整合數據分析的數位健康解決方案正日益受到關注，有助於改善疾病追蹤和應對。都市化加快和氣候變遷加劇了疾病的傳播，也對市場產生影響，為開發可擴充性、適應不同環境的診斷解決方案的公司創造了機會。

限制與挑戰：

被忽視的熱帶疾病診斷市場目前面臨許多重大限制和挑戰。其中最嚴重的是研發資金和資源投入不足，阻礙了創新和先進診斷工具的應用。這種資金限制在這些疾病高發生的低收入地區尤為突出。另一個重大挑戰是基礎設施匱乏，阻礙了偏遠地區診斷技術的應用和有效性。此外，缺乏訓練有素的醫護人員進行診斷測試和解讀結果，使情況更加複雜，導致誤診和治療無效。另外，與被忽視的熱帶疾病相關的文化障礙和社會污名也阻礙了人們及時尋求診斷和治療。監管障礙也阻礙了診斷產品在全球的分銷和推廣，因為不同地區的標準各不相同。最後，受影響地區不穩定的政治局勢擾亂了醫療衛生事業，使診斷活動的持續發展變得困難。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章 細分市場分析

  • 市場規模及預測：依類型
    • 寄生蟲病
    • 病毒性疾病
    • 細菌性疾病
    • 真菌病
    • 原蟲性疾病
    • 蠕蟲病
    • 媒介傳播疾病
    • 通用感染疾病
  • 市場規模及預測：依產品分類
    • 診斷試劑盒
    • 試劑
    • 裝置
    • 消耗品
    • 軟體
    • 配件
    • 偵測
    • 墨水匣
  • 市場規模及預測：依服務分類
    • 檢查服務
    • 諮詢服務
    • 維護服務
    • 培訓服務
    • 資料管理服務
  • 市場規模及預測：依技術分類
    • 分子診斷
    • 免疫檢測測定診斷
    • 層析法
    • 質譜分析
    • 微陣列
    • 即時檢測
    • 生物感測器
  • 市場規模及預測：依應用領域分類
    • 臨床診斷
    • 研究與開發
    • 流行病學研究
    • 公共衛生項目
    • 獸醫診斷
  • 市場規模及預測：依最終用戶分類
    • 醫院
    • 診斷檢查室
    • 研究所
    • 學術機構
    • 公共衛生機構
    • 獸醫診所
  • 市場規模及預測：依設備分類
    • 攜帶式裝置
    • 桌面設備
    • 穿戴式裝置
    • 行動裝置
  • 市場規模及預測：依製程分類
    • 樣本採集
    • 樣品製備
    • 分析
    • 數據解讀
    • 報告
  • 市場規模及預測：依組件分類
    • 硬體
    • 軟體
    • 服務

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 需求與供給差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 法規概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章 公司簡介

  • Chembio Diagnostics
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific
  • Meridian Bioscience
  • bioMerieux
  • Quidel Corporation
  • OraSure Technologies
  • Trinity Biotech
  • Abbott Laboratories
  • Hologic
  • QIAGEN
  • Novacyt
  • CTK Biotech
  • DiaSorin
  • GenMark Diagnostics

第9章：關於我們

簡介目錄
Product Code: GIS34078

Neglected Tropical Diseases Diagnosis Market is anticipated to expand from $6.7 billion in 2024 to $12.0 billion by 2034, growing at a CAGR of approximately 6.6%. The Neglected Tropical Diseases Diagnosis Market encompasses diagnostic tools and technologies designed to identify diseases often overlooked in low-income regions, such as Chagas disease, leishmaniasis, and schistosomiasis. This market focuses on affordable, rapid, and accurate diagnostic solutions to enhance early detection and treatment. Increasing global health initiatives and investments in research and development are propelling advancements in point-of-care testing and molecular diagnostics, addressing the urgent need for accessible healthcare solutions in underserved populations.

The Neglected Tropical Diseases Diagnosis Market is poised for significant growth, driven by advancements in diagnostic technologies and increasing awareness. The serological tests segment is the top-performing sub-segment, owing to its accuracy and rapid results, essential for early disease detection. Molecular diagnostics follow closely, benefiting from the rising adoption of PCR and next-generation sequencing technologies, which offer precise pathogen identification. Point-of-care diagnostics are gaining traction, especially in remote and resource-limited settings, due to their portability and ease of use. The demand for innovative diagnostic solutions is further bolstered by public and private sector investments aimed at eradicating neglected tropical diseases. Immunoassays, particularly ELISA, remain a cornerstone in the diagnostic toolkit, while novel biomarker discovery continues to enhance test specificity and sensitivity. Collaborative efforts among research institutions, governments, and healthcare providers are pivotal in driving market expansion, ensuring accessibility and affordability of diagnostic tools in endemic regions.

Market Segmentation
TypeParasitic Diseases, Viral Diseases, Bacterial Diseases, Fungal Diseases, Protozoan Diseases, Helminthic Diseases, Vector-Borne Diseases, Zoonotic Diseases
ProductDiagnostic Kits, Reagents, Instruments, Consumables, Software, Accessories, Assays, Cartridges
ServicesLaboratory Services, Consultation Services, Maintenance Services, Training Services, Data Management Services
TechnologyMolecular Diagnostics, Immunoassay Diagnostics, Chromatography, Mass Spectrometry, Microarray, Point-of-Care Testing, Biosensors
ApplicationClinical Diagnostics, Research and Development, Epidemiological Studies, Public Health Programs, Veterinary Diagnostics
End UserHospitals, Diagnostic Laboratories, Research Institutes, Academic Institutions, Public Health Organizations, Veterinary Clinics
DevicePortable Devices, Benchtop Devices, Wearable Devices, Handheld Devices
ProcessSample Collection, Sample Preparation, Analysis, Data Interpretation, Reporting
ComponentHardware, Software, Services

Market Snapshot:

The Neglected Tropical Diseases (NTD) Diagnosis Market is witnessing a dynamic shift with increasing market share driven by innovative pricing strategies and a surge in new product launches. Companies are focusing on affordability and accessibility, which is crucial for markets in developing regions. Recent product innovations are enhancing diagnostic accuracy and speed, catering to the urgent need for effective solutions. These developments are fostering a competitive landscape, encouraging continuous advancements and strategic collaborations. Competition in the NTD Diagnosis Market is intensifying, with key players benchmarking against each other to maintain market dominance. Regulatory influences are pivotal, as stringent guidelines ensure the safety and efficacy of diagnostic tools. The market is shaped by policies from global health organizations, influencing product development and approval processes. Emerging economies are contributing to market growth, supported by increased funding and awareness. The landscape is further enriched by technological integration, promising enhanced diagnostic capabilities and market expansion.

Geographical Overview:

The Neglected Tropical Diseases (NTD) Diagnosis Market is expanding across diverse regions, each with unique growth dynamics. Africa remains a focal point, driven by a high prevalence of NTDs and increased governmental and non-governmental interventions. Efforts to improve healthcare infrastructure and diagnostic capabilities are bolstering market growth. In Asia Pacific, countries like India and Indonesia are witnessing rapid advancements due to significant investments in healthcare and diagnostic technologies. This region's large population and rising healthcare awareness contribute to its market expansion. Latin America, particularly Brazil, is emerging as a promising market, with increased public health initiatives and government support for NTD diagnosis. The Middle East is also gaining traction, with countries like Saudi Arabia and the UAE investing in healthcare innovations to combat NTDs. These emerging markets present lucrative opportunities for stakeholders aiming to address the global NTD burden through improved diagnostic solutions.

Key Trends and Drivers:

The Neglected Tropical Diseases Diagnosis Market is experiencing growth due to increased awareness and global health initiatives. Governments and organizations are investing in research and development to improve diagnostic tools. This trend is driven by the urgent need to address diseases affecting vulnerable populations. Technological advancements are pivotal, with innovations in rapid diagnostics and point-of-care testing. These technologies offer quicker, more accurate results, enhancing disease management and control. As a result, there is a growing demand for portable and easy-to-use diagnostic devices. Public-private partnerships are emerging as a key driver, fostering collaboration between stakeholders. These alliances are crucial for funding and resource allocation, ensuring widespread access to diagnostics. Additionally, digital health solutions are gaining traction, integrating data analytics to improve disease tracking and response. The market is also influenced by increasing urbanization and climate change, which exacerbate disease spread. This creates opportunities for companies to develop adaptable and scalable diagnostic solutions tailored to diverse environments.

Restraints and Challenges:

The Neglected Tropical Diseases Diagnosis Market is currently grappling with several critical restraints and challenges. Foremost among these is the limited funding and resource allocation for research and development, which stifles innovation and the introduction of advanced diagnostic tools. This financial constraint is particularly pronounced in low-income regions where these diseases are most prevalent. Another significant challenge is the lack of infrastructure, which hampers the deployment and effectiveness of diagnostic technologies in remote areas. Moreover, the scarcity of trained healthcare professionals to administer and interpret diagnostic tests further complicates the situation, leading to misdiagnoses and ineffective treatment. Additionally, cultural barriers and stigma associated with neglected tropical diseases dissuade individuals from seeking timely diagnosis and care. Regulatory hurdles also pose a challenge, as varying standards across regions impede the global distribution and acceptance of diagnostic products. Lastly, the volatile political environments in affected regions can disrupt healthcare initiatives, making it difficult to sustain diagnostic efforts.

Key Players:

Chembio Diagnostics, Bio-Rad Laboratories, Thermo Fisher Scientific, Meridian Bioscience, bioMerieux, Quidel Corporation, OraSure Technologies, Trinity Biotech, Abbott Laboratories, Hologic, QIAGEN, Novacyt, CTK Biotech, DiaSorin, GenMark Diagnostics

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Device
  • 2.8 Key Market Highlights by Process
  • 2.9 Key Market Highlights by Component

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Parasitic Diseases
    • 4.1.2 Viral Diseases
    • 4.1.3 Bacterial Diseases
    • 4.1.4 Fungal Diseases
    • 4.1.5 Protozoan Diseases
    • 4.1.6 Helminthic Diseases
    • 4.1.7 Vector-Borne Diseases
    • 4.1.8 Zoonotic Diseases
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Diagnostic Kits
    • 4.2.2 Reagents
    • 4.2.3 Instruments
    • 4.2.4 Consumables
    • 4.2.5 Software
    • 4.2.6 Accessories
    • 4.2.7 Assays
    • 4.2.8 Cartridges
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Laboratory Services
    • 4.3.2 Consultation Services
    • 4.3.3 Maintenance Services
    • 4.3.4 Training Services
    • 4.3.5 Data Management Services
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Molecular Diagnostics
    • 4.4.2 Immunoassay Diagnostics
    • 4.4.3 Chromatography
    • 4.4.4 Mass Spectrometry
    • 4.4.5 Microarray
    • 4.4.6 Point-of-Care Testing
    • 4.4.7 Biosensors
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Clinical Diagnostics
    • 4.5.2 Research and Development
    • 4.5.3 Epidemiological Studies
    • 4.5.4 Public Health Programs
    • 4.5.5 Veterinary Diagnostics
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Hospitals
    • 4.6.2 Diagnostic Laboratories
    • 4.6.3 Research Institutes
    • 4.6.4 Academic Institutions
    • 4.6.5 Public Health Organizations
    • 4.6.6 Veterinary Clinics
  • 4.7 Market Size & Forecast by Device (2020-2035)
    • 4.7.1 Portable Devices
    • 4.7.2 Benchtop Devices
    • 4.7.3 Wearable Devices
    • 4.7.4 Handheld Devices
  • 4.8 Market Size & Forecast by Process (2020-2035)
    • 4.8.1 Sample Collection
    • 4.8.2 Sample Preparation
    • 4.8.3 Analysis
    • 4.8.4 Data Interpretation
    • 4.8.5 Reporting
  • 4.9 Market Size & Forecast by Component (2020-2035)
    • 4.9.1 Hardware
    • 4.9.2 Software
    • 4.9.3 Services

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Device
      • 5.2.1.8 Process
      • 5.2.1.9 Component
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Device
      • 5.2.2.8 Process
      • 5.2.2.9 Component
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Device
      • 5.2.3.8 Process
      • 5.2.3.9 Component
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Device
      • 5.3.1.8 Process
      • 5.3.1.9 Component
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Device
      • 5.3.2.8 Process
      • 5.3.2.9 Component
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Device
      • 5.3.3.8 Process
      • 5.3.3.9 Component
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Device
      • 5.4.1.8 Process
      • 5.4.1.9 Component
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Device
      • 5.4.2.8 Process
      • 5.4.2.9 Component
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Device
      • 5.4.3.8 Process
      • 5.4.3.9 Component
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Device
      • 5.4.4.8 Process
      • 5.4.4.9 Component
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Device
      • 5.4.5.8 Process
      • 5.4.5.9 Component
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Device
      • 5.4.6.8 Process
      • 5.4.6.9 Component
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Device
      • 5.4.7.8 Process
      • 5.4.7.9 Component
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Device
      • 5.5.1.8 Process
      • 5.5.1.9 Component
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Device
      • 5.5.2.8 Process
      • 5.5.2.9 Component
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Device
      • 5.5.3.8 Process
      • 5.5.3.9 Component
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Device
      • 5.5.4.8 Process
      • 5.5.4.9 Component
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Device
      • 5.5.5.8 Process
      • 5.5.5.9 Component
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Device
      • 5.5.6.8 Process
      • 5.5.6.9 Component
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Device
      • 5.6.1.8 Process
      • 5.6.1.9 Component
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Device
      • 5.6.2.8 Process
      • 5.6.2.9 Component
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Device
      • 5.6.3.8 Process
      • 5.6.3.9 Component
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Device
      • 5.6.4.8 Process
      • 5.6.4.9 Component
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Device
      • 5.6.5.8 Process
      • 5.6.5.9 Component

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Chembio Diagnostics
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Bio-Rad Laboratories
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Thermo Fisher Scientific
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Meridian Bioscience
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 bioMerieux
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Quidel Corporation
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 OraSure Technologies
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Trinity Biotech
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Abbott Laboratories
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Hologic
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 QIAGEN
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Novacyt
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 CTK Biotech
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 DiaSorin
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 GenMark Diagnostics
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us